Biodesix Stock Odds of Future Stock Price Finishing Over 5.50
| BDSX Stock | USD 1.44 0.11 8.27% |
Biodesix |
Biodesix Target Price Odds to finish over 5.50
The tendency of Biodesix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 5.50 or more in 90 days |
| 1.44 | 90 days | 5.50 | close to zero percent |
Based on a normal probability distribution, the odds of Biodesix to move over $ 5.50 or more in 90 days from now is close to zero percent (This Biodesix probability density function shows the probability of Biodesix Stock to fall within a particular range of prices over 90 days) . Probability of Biodesix price to stay between its current price of $ 1.44 and $ 5.50 at the end of the 90-day period is about 81.59 .
Given the investment horizon of 90 days Biodesix has a beta of -0.0978 suggesting as returns on the benchmark increase, returns on holding Biodesix are expected to decrease at a much lower rate. During a bear market, however, Biodesix is likely to outperform the market. Additionally Biodesix has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Biodesix Price Density |
| Price |
Predictive Modules for Biodesix
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biodesix. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biodesix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biodesix Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biodesix is not an exception. The market had few large corrections towards the Biodesix's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biodesix, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biodesix within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.37 | |
β | Beta against Dow Jones | -0.1 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | -0.12 |
Biodesix Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biodesix for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biodesix can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biodesix generated a negative expected return over the last 90 days | |
| Biodesix may become a speculative penny stock | |
| Biodesix has high historical volatility and very poor performance | |
| Biodesix has a very high chance of going through financial distress in the upcoming years | |
| Biodesix currently holds 60.69 M in liabilities with Debt to Equity (D/E) ratio of 3.2, implying the company greatly relies on financing operations through barrowing. Biodesix has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biodesix's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 49.09 M. Net Loss for the year was (52.15 M) with profit before overhead, payroll, taxes, and interest of 24.06 M. | |
| Biodesix currently holds about 15.18 M in cash with (22.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| Biodesix has a poor financial position based on the latest SEC disclosures | |
| Roughly 47.0% of Biodesix shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 2781 shares by Scott Hutton of Biodesix at 1.601 subject to Rule 16b-3 |
Biodesix Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biodesix Stock often depends not only on the future outlook of the current and potential Biodesix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biodesix's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.1 M | |
| Cash And Short Term Investments | 26.3 M |
Biodesix Technical Analysis
Biodesix's future price can be derived by breaking down and analyzing its technical indicators over time. Biodesix Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biodesix. In general, you should focus on analyzing Biodesix Stock price patterns and their correlations with different microeconomic environments and drivers.
Biodesix Predictive Forecast Models
Biodesix's time-series forecasting models is one of many Biodesix's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biodesix's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biodesix
Checking the ongoing alerts about Biodesix for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biodesix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biodesix generated a negative expected return over the last 90 days | |
| Biodesix may become a speculative penny stock | |
| Biodesix has high historical volatility and very poor performance | |
| Biodesix has a very high chance of going through financial distress in the upcoming years | |
| Biodesix currently holds 60.69 M in liabilities with Debt to Equity (D/E) ratio of 3.2, implying the company greatly relies on financing operations through barrowing. Biodesix has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biodesix's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 49.09 M. Net Loss for the year was (52.15 M) with profit before overhead, payroll, taxes, and interest of 24.06 M. | |
| Biodesix currently holds about 15.18 M in cash with (22.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| Biodesix has a poor financial position based on the latest SEC disclosures | |
| Roughly 47.0% of Biodesix shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 2781 shares by Scott Hutton of Biodesix at 1.601 subject to Rule 16b-3 |
Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.